15
REVIEW Amyloidosis Clerk: 吳吳吳

Amyloidosis in head and neck manifestation

Embed Size (px)

Citation preview

Page 1: Amyloidosis in head and neck manifestation

REVIEWAmyloidosis

Clerk: 吳昱甫

Page 2: Amyloidosis in head and neck manifestation

Introduction• Amyloidosis definition: Extracellular deposits of fibrillary proteins• Binds wide variety of proteoglycans (蛋白聚糖 ) and glycosaminoglycans (葡萄胺聚糖 )• E.G. heparin sulfate, dermatan sulfate,

plasma proteins, serum amyloid P component

Page 3: Amyloidosis in head and neck manifestation

Amylose• Proteoglycans &

glycosaminoglycans• Resembled starch• Unstable and self-

associated• Full of β-sheet polypeptide chains• They are called Fibrils

doi: 10.1073/pnas.1202071109

Page 4: Amyloidosis in head and neck manifestation

Fibrils Formation

http://www.chem.umass.edu/~vachet/Research.html

Page 5: Amyloidosis in head and neck manifestation

Amyloid• Consisted by

fibrils• Congo-red• Apple-green

birefringence

Robbins Pathology, 9/e

Page 6: Amyloidosis in head and neck manifestation

Pathogenesis• Normally, misfolded proteins are

degraded intracellularly in proteasomes, or extracellularly by macrophages.• It appears that in amyloidosis, these

quality control mechanisms fail, allowing the misfolding protein to accumulate outside cells.• Disease depends on where it deposits

Page 7: Amyloidosis in head and neck manifestation

Pathogenesis

Robbins Pathology, 9/e

Page 8: Amyloidosis in head and neck manifestation

Classification• Primary amyloidosis

• AL form• Most common form of amyloidosis• 5% to 15% of patients have multiple myeloma

• Reactive systemic amyloidosis• AA form• Chronic infection (TB, osteomyelitis,

skin-infection)• Chronic inflammation (autoimmune related:

IBD, RA)• Tumors (RCC, Hodgkin lymphoma)

Page 9: Amyloidosis in head and neck manifestation

Classification• Familial (hereditary) amyloidosis• Familial Mediterranean fever (pyrin and

inflammasome)• Localized amyloidosis• Nodular deposits• Infiltration of plasma cells and lymphocytes

• Amyloidosis of Aging• TTR type• Senile cardiac amyloidosis

Page 10: Amyloidosis in head and neck manifestation

Morphology – Kidney• Most common in organs (and most

serious)• Deposited principally in glomeruli• Within mesangial matrix

• Clinical course• Nephrotic syndrome• With severe proteinuria

http://www.pathologyatlas.ro/amyloidosis-kidney-pathology.php

Page 11: Amyloidosis in head and neck manifestation

Morphology - Heart• Usually the AL form• Senile amyloidosis, TTR form• Deposited principally between myocardial fibers• Clinical course• Conduction

disturbance• Arrhythmias• Cardiomyopathy

http://www.e-heart.org/Pages/03_Cardiomyopathy/03_Cardiomyopathy_Amyloidosis_006.htm

Page 12: Amyloidosis in head and neck manifestation

Back to The Case

Page 13: Amyloidosis in head and neck manifestation

Back to The Case• Laryngeal amyloidosis is rare, accounting

for 0.5-1% of benign laryngeal tumors. • However, the larynx is one of the more common sites in the head and neck for amyloid deposition. • In contrast with tongue amyloidosis,

laryngeal involvement is usually due to a localized deposition of AL amyloid, and is only rarely a manifestation of systemic amyloidosis.

Page 14: Amyloidosis in head and neck manifestation

Back to The Case• The most common presenting symptom is slowly progressive dysphonia; acute airway compromise is rare. • Amyloid deposition may cause diffuse

thickening of the true or false cords. • Discrete lesions take the form of smooth,

non-ulcerative swellings around 1.5 cm across, and may occur anywhere in the supraglottis, glottis or subglottis. • Amyloid deposition in the hypopharynx is

very rare.

Page 15: Amyloidosis in head and neck manifestation

Reference1. Robbins Pathology, 9/e2. The Systemic Amyloidoses, Rodney H. Falk,

M.D., Raymond L. Comenzo, M.D., and Martha Skinner, M.D.; N Engl J Med 1997; 337:898-909

3. Molecular Mechanisms of Amyloidosis, Giampaolo Merlini, M.D., and Vittorio Bellotti, M.D., Ph.D.; N Engl J Med 2003; 349:583-596

4. Head and neck manifestations of amyloidosis; The Otorhinolaryngologist 2013; 6(1): 35–40